Updated: Feb 21
Almost every industry is evolving to meet growing consumer demands, whether technological, medical, or consumer based. Going on behind the scenes is the rapid growth that takes place in the biotech industry. Here, we explore five rising biotech-based technologies and how they provide innovation, expansion, and value to the world around us.
CRISPR Gene Editing
Advancements in gene editing techniques, like CRISPR, paved the way for a better understanding and breakdown of specific genomes in molecular biology. CRISPR is an incredibly innovative technology in the biotech industry that equips researchers, scientists, and engineers with the unique ability to modify a living organism with increased precision and affordability.
The advantage of CRISPR is allowing biotech and medicine to use in-vivo methods to open the DNA and make alterations. These efforts bring a better understanding of genetic disorders and conditions through targeted modifications that edit, replace, add or silence variable genetic sequences.
Synthetic Genetic Network Biology
An emerging and globally beneficial innovation in the biotech industry is breaking barriers with synthetic genetic networking biology. This network is the ideal crossroad for multiple industries to merge and change how researchers and engineers work together to find resolutions in agriculture, medicine, and manufacturing.
Synthetic genetic biology lends a hand in everyday life through various medically appointed methods. Through the distinct use of mammalian cells and synthesized gene circuits, scientists have a better understanding of various human genetic diseases, including potential metabolic disorders. An example of this is encoding a mice’s liver with a shunt pathway that helps increase the overall oxidation of fatty acids.
The biotech industry can use immunotherapy to bring more customized and ideal treatment plans to patients seeking treatment. By collecting the patient’s distinct genetic codes, oncologists can read this information and apply it to a more refined cancer treatment plan. Additionally, the DNA present in the formation of the cancer cells or tumors will indicate which cells are under attack and which cells mutate.
Proteomics plays a fundamental role in protein engagement and interaction inside the cell. The result of a proteome allows for a more precise understanding of the cell’s state, and the biotech industry relies on proteomics to produce higher, more reliable results for therapeutic monitoring measures and disease markers. The technologies used for high-throughput proteomics combine bioinformatics for an increased understanding of molecular indicators that correspond to the protein’s pathways.
Genetic sequencing has fallen rapidly in cost, and because of this, more industries can participate in its technology and benefit from further research efforts. This expansion in access is creating enhanced medical applications for personalized and pediatric measures and evolving phenotyping technologies.
Through the cost-effectiveness of gene sequencing, biotech companies have a better understanding of microbial occurrences through variable settings such as clinical pathogen studies, soil-based microbes, and the gut microbiome.
Bon Opus Biosciences
Gaining affordable and accessible bioscience and biotech services is easier than ever, as evidenced by the biotech industry’s emerging and innovative transformations. Bon Opus Biosciences paves the way for recombinant protein suppliers and curates a custom, affordable environment for all genetic and bio-based research efforts. Partner with us today to learn more about our distinct services.